SCHEMBL25224878

SCHEMBL25224878

O=CC1CCCN1C(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29953388 0.94 — —
SCHEMBL8350061 0.78 CHRM3 (0.32) —
SCHEMBL14310363 0.78 CHRM3 (0.32) —
SCHEMBL29005240 0.78 — —
SCHEMBL16864502 0.76 — —
SCHEMBL16542281 0.75 — —
SCHEMBL17346685 0.75 CHRM4 (0.31) —
SCHEMBL12642741 0.74 L3MBTL1 (0.39) —
SCHEMBL13406669 0.74 L3MBTL1 (0.39) —
SCHEMBL13850386 0.72 PARP1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4271676-A1 CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE Bionova Pharmaceuticals (Shanghai) Limited (CN) 2023-11-08 — — EP disclosed
WO-2023098876-A1 CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE BIONOVA PHARMACEUTICALS (SHANGHAI) LIMITED (CN) 2023-06-08 — — WO disclosed
Send feedback